CVI Holdings’s Fibrocell Science Inc. FCSC Stock Holding History

CVI Holdings’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-117,099	Closed	-$317K	–	63
2018 Q2	$317K	Buy	+117,099	New	+$339K	0.39%	27

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CVI Holdings's FCSC Position: Q3 2018 in Review

CVI Holdings sold out of Fibrocell Science Inc. (FCSC) in Q3 2018, closing a stake of 117,099 shares — an estimated $317K sold.

CVI Holdings first reported a position in FCSC in Q2 2018 and held it in 1 quarter. The position peaked at $317K in Q2 2018. 25 funds tracked by Wall St. Rank hold FCSC as of Q3 2018.

CVI Holdings reported no remaining Fibrocell Science Inc. position as of Q3 2018 after selling out during the quarter.
CVI Holdings sold 117,099 Fibrocell Science Inc. shares in Q3 2018, an estimated $317K.
CVI Holdings first reported a position in Fibrocell Science Inc. in Q2 2018 and held it in 1 quarter.
CVI Holdings's Fibrocell Science Inc. position peaked at $317K in Q2 2018.
25 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q3 2018.

Based on CVI Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.